Skip to main content
CareCloud Inc (CCLD)
Computer Software and Services Information Technology
Stock AI

CareCloud Inc. Executes Mandatory Conversion of Series A Preferred Stock

Last updated: March 06, 2025
Taurigo

1. Transformative Move to Enhance Financial Flexibility

On March 6, 2025, CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a prominent player in healthcare information technology and generative AI solutions, announced a significant financial maneuver: the mandatory conversion of its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock into common stock. This strategic decision marks a pivotal moment for the company, aimed at improving its capital structure and fueling future growth.

2. Eliminating Dividend Obligations

The conversion will effectively eliminate approximately $7 million or more in annual dividend obligations associated with the preferred stock. Norman Roth, Interim Chief Financial Officer and Corporate Controller of CareCloud, expressed enthusiasm about this development. “We are excited to announce this conversion, which will eliminate approximately $7 million or more in annual dividend obligations, freeing us to reinvest this capital in our growth,” he stated. This move is anticipated to provide CareCloud with a cleaner capital structure and enhanced flexibility, allowing the company to focus on creating value for its shareholders.

3. Details of the Conversion

The Board of Directors of CareCloud exercised its conversion rights, which stipulate that each share of the Preferred Stock will convert into 7.3358 shares of Common Stock. This conversion includes all accumulated and unpaid dividends. Notably, any fractional shares that arise from this conversion will be rounded up to the next whole share of Common Stock. As of the Mandatory Exchange Date at 4:01 p.m. Eastern Time on March 6, 2025, dividends on the converted shares will cease to accrue.

It is important to note that individual shareholders who own at least 100,000 shares of Preferred Stock as of the Mandatory Exchange Date will not see their shares automatically converted if held by the Company’s transfer agent. These shareholders retain a limited right to object to the conversion, ensuring that their interests are safeguarded during this transition.

4. Implications for Shareholders

The conversion of the Preferred Stock into Common Stock is poised to enhance CareCloud's financial position, providing the company with additional resources to invest in its innovative solutions. CareCloud's suite of technology-enabled solutions has already garnered the trust of over 40,000 healthcare providers nationwide, significantly improving patient care while minimizing administrative burdens and operational costs.

This strategic shift not only fortifies CareCloud's balance sheet but also aligns with its mission to drive disciplined innovation in the healthcare sector. The company focuses on enhancing financial and operational performance while streamlining clinical workflows and improving the patient experience.

5. Looking Ahead

As CareCloud moves forward with this conversion, the healthcare IT landscape continues to evolve rapidly. The company’s commitment to leveraging generative AI and advanced technology solutions will be crucial as it seeks to navigate the complexities of the industry while delivering value to its shareholders.

Investors and stakeholders can find additional information regarding the conversion in the Amended and Restated Certificate of Designations, Preferences, and Rights of the 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock, available on the Securities and Exchange Commission's website.

CareCloud's announcement reflects a significant step towards enhancing its financial flexibility and positioning itself for future growth in the dynamic healthcare technology market.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.